Published in Lab Business Week, April 29th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Oncolytics Biotech.
Report 1: Oncolytics Biotech Inc. (ONC, ONCY) announced the appointment of Mary Ann Dillahunty as vice president, Intellectual Property.
Report 2: Oncolytics Biotech Inc. (ONC, ONCY) has completed patient enrollment in its Phase I U.S. clinical trial investigating the systemic delivery of Reolysin to treat patients with advanced cancers.
Eighteen patients were treated in the Phase I trial with Reolysin at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.